搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
FierceBiotech
12 小时
UPDATED: Astellas unveils new Japan site for cell therapy research arm Universal Cells ...
Some six years after picking up Seattle’s Universal Cells for $102 million, Astellas Pharma is opening a second location for ...
FierceBiotech
19 小时
Nobel Prize in Chemistry awarded to 3 scientists for predicting and designing proteins
A day after the Physics prize was given to two scientists for foundational work on machine learning, the Nobel Prize in ...
FierceBiotech
16 小时
ModeX's multispecific antibodies shut down COVID variants and advance to the clinic with ...
Modex’s antibodies contain multiple binding sites and can target several parts of SARS-CoV-2’s spike protein, the tool the ...
FierceBiotech
19 小时
ShiraTronics raises $66M for its neuromodulation implant for chronic migraines
After putting forward preliminary clinical data earlier this year from its neuromodulation implant for reducing chronic ...
FierceBiotech
18 小时
Illumina unveils benchtop DNA sequencer update with push-button workflows
Illumina is welcoming a new addition to its DNA sequencing lineup, with a pair of accessible benchtop instruments that ...
FierceBiotech
21 小时
Eli Lilly delivers for AI-powered insitro to clear siRNA molecules’ path to clinic
Insitro has teamed up with Eli Lilly to help power programs into the clinic, tapping the Big Pharma for an option on ...
FierceBiotech
21 小时
Boehringer unveils $607M deal to land Circle's preclinical cancer program
Boehringer Ingelheim has rolled into an alliance with undruggable target specialist Circle Pharma, putting together a package ...
FierceBiotech
21 小时
InnoCare's TYK2 inhibitor shows potential to rival Sotyktu in Chinese phase 2 psoriasis trial
InnoCare Pharma’s tyrosine kinase 2 (TYK2) inhibitor has hit the main goals of a phase 2 trial in China, sustaining the ...
FierceBiotech
23 小时
With Kezar stranded in lupus limbo, Concentra spies opportunity for next acquisition
With Kezar Life Sciences’ lupus plans up in the air while the company investigates patient deaths, Concentra Biosciences has ...
FierceBiotech
18 小时
Syneos Health lands former IQVIA R&D leader as CEO
Syneos Health has tapped Costa Panagos to take the reins from former CEO Colin Shannon, who will transition to the role of ...
FierceBiotech
1 天
Purespring bottles up $105M series B to bring kidney disease gene therapy to the clinic
London-based biotech Purespring Therapeutics plans to bring their kidney-tweaking gene therapy to the clinic with the help of ...
FierceBiotech
1 天
'Ongoing challenges' force Pfizer to scrap oral RSV med from ReViral buyout
In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈